Baker LE, Broadbent J, Michael EK, Matthews PK, Metosh CA, Saunders RB, West WB, Appel JB (1995) Assessment of the discriminative stimulus effects of the optical isomers of ecstasy (3,4-methylenedioxymethamphetamine; MDMA). Behav Pharmacol 6:263–275

CAS  PubMed  Google Scholar 

Bankson MG, Cunningham KA (2001) 3,4-Methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin-dopamine interactions. J Pharmacol Exp Ther 297:846–852

CAS  PubMed  Google Scholar 

Bankson MG, Cunningham KA (2002) Pharmacological studies of the acute effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT_1B/1D and 5-HT₂ receptors. Neuropsychopharmacology 26:40–52

Article  CAS  PubMed  Google Scholar 

Beardsley PM, Balster RL, Harris LS (1986) Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys. Drug Alcohol Depend 18:149–157

CAS  PubMed  Google Scholar 

Callaway CW, Geyer MA (1992) Tolerance and cross-tolerance to the activating effects of 3,4-methylenedioxymethamphetamine and a 5-hydroxytryptamine1B agonist. J Pharmacol Exp Ther 263:318–326

CAS  PubMed  Google Scholar 

Callaway CW, Wing L, Geyer MA (1990) Serotonin release contributes to the stimulant effects of 3,4-methylenedioxymethamphetamine in rats. J Pharmacol Exp Ther 254:456–464

CAS  PubMed  Google Scholar 

Carroll ME, Lac ST (1997) Acquisition of IV amphetamine and cocaine self-administration in rats as a function of dose. Psychopharmacology 129:206–214

Article  CAS  PubMed  Google Scholar 

De Deurwaerdere P, L'hirondel M, Bonhomme N, Lucas G, Cheramy A, Spaminato U (1997) Serotonin stimulation of 5-HT₄ receptors indirectly enhances in vivo dopamine release in the rat. J Neurochem 68:195–203

PubMed  Google Scholar 

Deneau G, Yanaghita T, Seevers MH (1969) Self-administration of psychoactive substances by the monkey. Psychopharmacologia 16:30–48

CAS  PubMed  Google Scholar 

Fantegrossi WE, Ullrich T, Rice KC, Woods JH, Winger G (2002) 3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement. Psychopharmacology 161:356–364

Google Scholar 

Fischman MW, Schuster CR (1978) Drug seeking: a behavioral analysis in animals and humans. NIDA Res Monogr 20:4–23

CAS  PubMed  Google Scholar 

Fletcher PJ, Robinson SR, Slippoy DL (2001) Pre-exposure to (±)3,4-methylenedioxymethamphetamine (MDMA) facilitates acquisition of intravenous cocaine self-administration in rats. Neuropsychopharmacology 25:195–203

Article  CAS  PubMed  Google Scholar 

Gudelsky GA, Yamamoto BK, Nash (1994) Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT₂ receptor agonists. Eur J Pharmacol 264:325–330

Article  CAS  PubMed  Google Scholar 

Hansen JP, Riddle EL, Sandoval V, Brown JM, Gibb JW, Hanson GR, Fleckenstein AE (2002) Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity. J Pharmacol Exp Ther 300:1093–1100

Google Scholar 

Hekmatpanah CR, Peroutka SJ (1990) 5-Hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methyenedioxymethamphetamine and related agents. Eur J Pharmacol 177:95–98

Article  CAS  PubMed  Google Scholar 

Hernandez-Lopez C, Farre M, Roset PN, Menoyo E, Pizarro N, Ortuno J, Torrens M, Cami J, de La Torre R (2002) 3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics. J Pharmacol Exp Ther 300:236–244

Google Scholar 

Herve D, Pickel VM, Joh TH, Beaudet A (1987) Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic terminals. Brain Res 435:71–83

CAS  PubMed  Google Scholar 

Horan B, Gardner EL, Ashby CR Jr (2000) Enhancement of conditioned place preference response to cocaine in rats following subchronic administration of 3,4-methylenedioxymethamphetamine (MDMA). Synapse 35:160–162

Article  CAS  PubMed  Google Scholar 

Howell LL, Wilcox KM (2001) The dopamine transporter and cocaine medication development: drug self-administration in nonhuman primates. J Pharmacol Exp Ther 298:1–6

PubMed  Google Scholar 

Iravani MM, Asari D, Patel J, Wieczorek WJ, Kruk ZL (2000) Direct effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin or dopamine release and uptake in the caudate putamen, nucleus accumbens, substantia nigra pars reticulata, and the dorsal raphe nucleus slices. Synapse 36:275–285

Article  CAS  PubMed  Google Scholar 

Kalant H (2001) The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs. CMAJ 165:917–928

CAS  PubMed  Google Scholar 

Kalivas PW, Stewart J (1991) Dopamine transmission in the initiation and expression of drug- and stress-induced sensitisation to motor activity. Brain Res Rev 16:223–244

CAS  PubMed  Google Scholar 

Kalivas PW, Duffy P, White SR (1998) MDMA elicits behavioral and neurochemical sensitization in rats. Neuropsychopharmacology 18:469–479

Google Scholar 

Kuhar MJ, Ritz M, Boja JW (1991) The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14:299–302

Google Scholar 

Lamb RJ, Griffiths RR (1987) Self-injection of d,1-3,4-methylenedioxymethamphetamine (MDMA) in the baboon. Psychopharmacology 91:268–272

CAS  PubMed  Google Scholar 

Liechti ME, Vollenweider FX (2000) Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans. Eur Neuropsychopharmacol 10:289–295

CAS  PubMed  Google Scholar 

Liechti ME, Vollenweider FX (2001) Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies. Hum Psychopharmacol Clin Exp 16:589–598

Google Scholar 

Marona-Lewicka D, Rhee GS, Sprague JE, Nichols DE (1991) MDL72222, a serotonin 5-HT₃ receptor antagonist, blocks MDMA's ability to establish a conditioned place preference. Pharmacol Biochem Behav 39:509–512

PubMed  Google Scholar 

Mayerhoffer A, Kovar K-A, Schmidt WJ (2001) Changes in serotonin, dopamine and noradrenaline levels in striatum and nucleus accumbens after repeated administration of the abused drug MDMA in rats. Neurosci Lett 308:99–102

Article  PubMed  Google Scholar 

McCreary AC, Bankson MG, Cunningham KA (1999) Pharmacological studies of the acute and chronic effects of (+)-3,4-methyenedioxymethamphetamine on locomotor activity: role of the 5-hydroxytryptamine_1A and 5-hydroxytryptamine_1B/1D receptors. J Pharmacol Exp Ther 290:965–973

CAS  PubMed  Google Scholar 

Mello NK, Negus SS (1996) Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 14:375–424

PubMed  Google Scholar 

Metzger RR, Hanson GR, Gibb JW, Fleckenstein AE (1998) 3,4-Methylenedioxymethamphetamine-induced acute changes in dopamine transporter function. Eur J Pharmacol 349:205–210

Article  CAS  PubMed  Google Scholar 

Nash JF, Brodkin J (1991) Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors. J Pharmacol Exp Ther 259:820–825

Google Scholar 

Ng N-K, Lee H-S, Wong PT-H (1999) Regulation of striatal dopamine release through 5-HT₁ and 5-HT₂ receptors. J Neurosci Res 55:600–607

Article  CAS  PubMed  Google Scholar 

Parrott AC (2002) Recreational ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity. Pharmacol Biochem Behav 71:837–844

Article  CAS  PubMed  Google Scholar 

Pederson W, Skrondal A (1999) Ecstasy and new patterns of drug use: a normal population study. Addiction 94:1695–1706

Article  CAS  PubMed  Google Scholar 

Piazza PV, Deminiere JM, Le Moal M, Simon H (1989) Factors that predict individual vulnerability to amphetamine self-administration. Science 245:1511

CAS  PubMed  Google Scholar 

Pierre PJ, Vezina P (1997) Predisposition to self-administer amphetamine: the contribution of response to novelty and prior exposure to the drug. Psychopharmacology 129:277–284

Article  CAS  PubMed  Google Scholar 

Pope HG, Ionescu-Pioggia M, Pope KW (2001) Drug use and life style among college undergraduates: a 30-year longitudinal study. Am J Psychiatry 158:1519–1521

Article  PubMed  Google Scholar 

Ratzenboeck, E, Saria A, Kriechbaum N, Zernig G (2001) Reinforcing effects of MDMA ("ecstasy") in drug-naive and cocaine-trained rats. Pharmacology 62:138–144

Article  CAS  PubMed  Google Scholar 

Robinson TE, Becker JB (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 396:157–198

CAS  PubMed  Google Scholar 

Rothman RB, Baumann MH, Dersch ChM, Romero DV, Rice KC, Carroll FI, Partilla JS (2001) Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39:32–41

CAS  PubMed  Google Scholar 

Rudnick G, Wall S (1992) The molecular mechanism of "ecstasy" [3,4-methylenedioxymethamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. Proc Natl Acad Sci USA 89:1817–1821

CAS  PubMed  Google Scholar 

Schenk S (2002) Sensitization as a process underlying the progression of drug use via "gateway" drugs. In: Kandel D (ed) Stages and pathways of drug involvement: examining the gateway hypothesis. Cambridge University Press, Cambridge, pp 318–336

Google Scholar 

Schenk S, Partridge B (1997) Sensitization and tolerance in psychostimulant self-administration. Pharmacol Biochem Behav 57:543–550

CAS  Google Scholar 

Schenk S, Partridge B (2000) Sensitization to cocaine's reinforcing effects produced by various cocaine pretreatment regimens in rats. Pharmacol Biochem Behav 66:765–770

CAS  PubMed  Google Scholar 

Schenk S, Partridge B (2001) Influence of a conditioned light stimulus in cocaine self-administration. Psychopharmacology 154:390–396

CAS  PubMed  Google Scholar 

Schenk S, Horger BA, Peltier R, Shelton K (1991) Supersensitivity to the reinforcing effects of cocaine following 6-hydroxydopamine lesions to the medial prefrontal cortex in rats. Brain Res 543:227–235

CAS  PubMed  Google Scholar 

Schenk S, Valadez A, McNamara C, House D, Higley D, Bankson MT, Gibbs S, Horger BA (1993) Development and expression of sensitization to cocaine's reinforcing properties: role of NMDA receptors. Psychopharmacology 111:332–338

CAS  PubMed  Google Scholar 

Schmidt CJ, Sullivan CK, Fadayel GN (1994) Blockade of striatal 5-HT₂ receptors reduced the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethamphetamine. J Neurochem 62:1382–1389

CAS  PubMed  Google Scholar 

Schuster CR, Thompson T (1969) Self administration of and behavioral dependence on drugs. Annu Rev Pharmacol 9:483–502

CAS  PubMed  Google Scholar 

Schuster P, Lieb R, Lamertz C, Wittchen HU (1998) Is the use of ecstasy and hallucinogens increasing? Results from a community study. Eur Addict Res 4:75–82

CAS  PubMed  Google Scholar 

Siliquini R, Faggiano F, Geninatti S, Versino E, Mitola B, Ippolito R (2001) Patterns of drug use among young men in Piedmont (Italy). Drug Alcohol Depend 64:329–335

Article  CAS  PubMed  Google Scholar 

Spanos LJ, Yamamoto BK (1989) Acute and subchronic effects of methylenedioxymethamphetamine [(±)MDMA] on locomotion and serotonin syndrome behavior in the rat. Pharmacol Biochem Behav 32:835–840

Article  CAS  PubMed  Google Scholar 

Spruit IP (2001) Monitoring synthetic drug markets, trends, and public health. Subst Use Misuse 36:23–47

Article  CAS  PubMed  Google Scholar 

Teter CJ, Guthrie SK (2001) A comprehensive review of MDMA and GHB: two common club drugs. Pharmacotherapy 21:1486–1513

CAS  PubMed  Google Scholar 

White SR, Obradovic T, Imel KM, Wheaton MJ (1996) The effects of methylenedioxymethamphetamine (MDMA,"Ecstasy") on monoaminergic neurotransmission in the central nervous system. Prog Neurobiol 49:455–479

CAS  PubMed  Google Scholar 

Wise RA, Rompre P-P (1989) Brain dopamine and reward. Annu Rev Psychol 40:191–225

CAS  PubMed  Google Scholar 

Yamamoto BK, Spanos J (1988) The acute effects of methylenedioxymethamphetamine on dopamine release in the awake behaving rat. Eur J Pharmacol 148:195–203

CAS  PubMed  Google Scholar 

Yan QS, Yan SE (2001) Activation of 5-HT(1B/1D) receptors in the mesolimbic dopamine system increases dopamine release from the nucleus accumbens: a microdialysis study. Eur J Pharmacol 418:55–64

CAS  PubMed  Google Scholar